Work

Vandetanib plus pernetrexed versus pemetrexed as 2nd-line therapy in patients with advanced NSCLC: a randomized, double-blind phase III trial (ZEAL)

Year: 2009

Type: article

Source: Journal of Thoracic Oncology

Authors: Richard H. De Boer, Óscar Arrieta, Maya Gottfried, Fiona Blackhall, Johann Raats, James Chih‐Hsin Yang, Peter Langmuir, Tsveta Milenkova, Jessica Read, Johan Vansteenkiste

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2520122907

FWCI:

Cites:

Cited by:

Related to: 10